Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1092808

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1092808

Europe Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 70 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Cancer Gene Therapy Market would witness market growth of 20.3% CAGR during the forecast period (2022-2028).

Favorable government therapeutic laws would further enhance numerous prospects, resulting in the expansion of the cancer gene therapy market over the projection period. However, high treatment costs and undesired immune reactions are projected to limit the growth of the cancer gene therapy market. In addition, compared to prior years, there was an increase in novel gene therapy pipeline developments in 2020. As a result, the number of clinical trials, product launches, collaborations, and product innovations are increasing.

Over the last few years, the gene therapy market has seen a series of changes. Initially, gene therapy for monogenetic illnesses was popular; however, the market for gene therapy for cancer treatment is growing in popularity. Cancer gene therapy is a method of treating cancer patients by putting therapeutic DNA into their bodies.

The German cancer gene has a lot of room for growth in the coming years. One of the primary reasons driving country growth is a better regulatory environment. Over the last few years, German regulatory authorities have simplified the regulatory process, making it easier for industry participants to advertise their medicines in Germany. Furthermore, a growing interest among healthcare experts in the availability of advanced cancer gene therapy would help the country prosper.

Lung cancer is caused by the uncontrollable proliferation of aberrant cells in one or both lungs. Persons who smoke have the highest risk of lung cancer, despite the fact that it can affect people who have never smoked. The time and number of cigarettes smoked by a patient increase the risk of lung cancer. Other risk factors include secondhand smoke, asbestos, certain metals, some organic compounds, radiation, air pollution, and diesel exhaust at the workplace or in the environment.

The Germany market dominated the Europe Cancer Gene Therapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $324.3 million by 2028. The UK market is poised to grow at a CAGR of 19.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 21.2% during (2022 - 2028).

Based on Therapy, the market is segmented into Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer. Based on End User, the market is segmented into Hospitals, Diagnostic centers and Research Institutes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, GlaxoSmithKline PLC (GSK), Amgen, Inc., Bristol Myers, Squibb Company, Karyopharm Therapeutics, Inc., Gilead Sciences, Inc., Adaptimmune Limited, Genelux Corporation, and Sarepta Therapeutics, Inc

Scope of the Study

Market Segments covered in the Report:

By Therapy

  • Gene Induced Immunotherapy
  • Oncolytic Virotherapy, and
  • Gene Transfer

By End User

  • Hospitals
  • Diagnostic centers
  • Research Institutes

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Novartis AG
  • GlaxoSmithKline PLC (GSK)
  • Amgen, Inc.
  • Bristol Myers Squibb Company
  • Karyopharm Therapeutics, Inc.
  • Gilead Sciences, Inc.
  • Adaptimmune Limited
  • Genelux Corporation
  • Sarepta Therapeutics, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Cancer Gene Therapy Market, by Therapy
    • 1.4.2 Europe Cancer Gene Therapy Market, by End User
    • 1.4.3 Europe Cancer Gene Therapy Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Cancer Gene Therapy Market by Therapy

  • 3.1 Europe Gene Induced Immunotherapy Market by Country
  • 3.2 Europe Oncolytic Virotherapy Market by Country
  • 3.3 Europe Gene Transfer Market by Country

Chapter 4. Europe Cancer Gene Therapy Market by End User

  • 4.1 Europe Hospitals Market by Country
  • 4.2 Europe Diagnostic centers Market by Country
  • 4.3 Europe Research Institutes Market by Country

Chapter 5. Europe Cancer Gene Therapy Market by Country

  • 5.1 Germany Cancer Gene Therapy Market
    • 5.1.1 Germany Cancer Gene Therapy Market by Therapy
    • 5.1.2 Germany Cancer Gene Therapy Market by End User
  • 5.2 UK Cancer Gene Therapy Market
    • 5.2.1 UK Cancer Gene Therapy Market by Therapy
    • 5.2.2 UK Cancer Gene Therapy Market by End User
  • 5.3 France Cancer Gene Therapy Market
    • 5.3.1 France Cancer Gene Therapy Market by Therapy
    • 5.3.2 France Cancer Gene Therapy Market by End User
  • 5.4 Russia Cancer Gene Therapy Market
    • 5.4.1 Russia Cancer Gene Therapy Market by Therapy
    • 5.4.2 Russia Cancer Gene Therapy Market by End User
  • 5.5 Spain Cancer Gene Therapy Market
    • 5.5.1 Spain Cancer Gene Therapy Market by Therapy
    • 5.5.2 Spain Cancer Gene Therapy Market by End User
  • 5.6 Italy Cancer Gene Therapy Market
    • 5.6.1 Italy Cancer Gene Therapy Market by Therapy
    • 5.6.2 Italy Cancer Gene Therapy Market by End User
  • 5.7 Rest of Europe Cancer Gene Therapy Market
    • 5.7.1 Rest of Europe Cancer Gene Therapy Market by Therapy
    • 5.7.2 Rest of Europe Cancer Gene Therapy Market by End User

Chapter 6. Company Profiles

  • 6.1 Novartis AG
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 GlaxoSmithKline PLC (GSK)
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Amgen, Inc.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Regional Analysis
    • 6.3.4 Research & Development Expenses
  • 6.4 Bristol Myers Squibb Company
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional Analysis
    • 6.4.4 Research & Development Expenses
  • 6.5 Karyopharm Therapeutics, Inc.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Research & Development Expense
  • 6.6 Gilead Sciences, Inc.
    • 6.6.1 Company overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Research & Development Expenses
  • 6.7 Adaptimmune Limited
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Research & Development Expenses
  • 6.8 Genelux Corporation
    • 6.8.1 Company Overview
  • 6.9 Sarepta Therapeutics, Inc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Europe Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 3 Europe Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 4 Europe Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 5 Europe Gene Induced Immunotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Europe Gene Induced Immunotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Europe Oncolytic Virotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Europe Oncolytic Virotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Europe Gene Transfer Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Gene Transfer Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 12 Europe Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 13 Europe Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Europe Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Europe Diagnostic centers Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Diagnostic centers Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Europe Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Europe Cancer Gene Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Europe Cancer Gene Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Germany Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 22 Germany Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 23 Germany Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 24 Germany Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 25 Germany Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 26 Germany Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 27 UK Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 28 UK Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 29 UK Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 30 UK Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 31 UK Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 32 UK Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 33 France Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 34 France Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 35 France Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 36 France Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 37 France Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 38 France Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 39 Russia Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 40 Russia Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 41 Russia Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 42 Russia Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 43 Russia Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 44 Russia Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 45 Spain Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 46 Spain Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 47 Spain Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 48 Spain Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 49 Spain Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 50 Spain Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 51 Italy Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 52 Italy Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 53 Italy Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 54 Italy Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 55 Italy Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 56 Italy Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 57 Rest of Europe Cancer Gene Therapy Market, 2018 - 2021, USD Million
  • TABLE 58 Rest of Europe Cancer Gene Therapy Market, 2022 - 2028, USD Million
  • TABLE 59 Rest of Europe Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
  • TABLE 60 Rest of Europe Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
  • TABLE 61 Rest of Europe Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
  • TABLE 62 Rest of Europe Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
  • TABLE 63 Key Information - Novartis AG
  • TABLE 64 Key Information - GlaxoSmithKline PLC (GSK)
  • TABLE 65 Key Information - Amgen, Inc.
  • TABLE 66 Key Information - Bristol Myers Squibb Company
  • TABLE 67 key Information - Karyopharm Therapeutics, Inc.
  • TABLE 68 Key Information - Gilead Sciences, Inc.
  • TABLE 69 Key information - Adaptimmune Limited
  • TABLE 70 Key Information - Genelux Corporation
  • TABLE 71 key information - Sarepta Therapeutics, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Novartis AG
  • FIG 3 Recent strategies and developments: Bristol Myers Squibb Company
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!